Please assess the completion status of the following clinical trial:

Trial Title: A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* On a stable daily dose of atorvastatin, rosuvastatin or simvastatin.~* Lipids meet the following criteria at screening and prior to dosing: Fasting LDL-C greater than 100 mg/dL and fasting TG less than 400 mg/dL~Exclusion Criteria:~* History of a cardiovascular or cerebrovascular event or procedure during the past year.~* Poorly controlled type 1 or type 2 diabetes mellitus.~* Poorly controlled hypertension.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment A (Type: PLACEBO_COMPARATOR): None
- Treatment B (Type: EXPERIMENTAL): None
- Treatment C (Type: EXPERIMENTAL): None
- Treatment D (Type: EXPERIMENTAL): None
- Treatment E (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).